Home000100 • KRX
add
Yuhan Corp
Previous close
₩120,700.00
Day range
₩117,500.00 - ₩119,800.00
Year range
₩100,400.00 - ₩166,900.00
Market cap
9.59T KRW
Avg Volume
317.98K
P/E ratio
110.57
Dividend yield
0.42%
Market news
Financials
Income Statement
Revenue
Net income
| (KRW) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 578.99B | 9.59% |
Operating expense | 149.06B | 0.31% |
Net income | 45.53B | 42.02% |
Net profit margin | 7.86 | 29.49% |
Earnings per share | 617.00 | 44.16% |
EBITDA | 67.56B | 94.59% |
Effective tax rate | 14.70% | — |
Balance Sheet
Total assets
Total liabilities
| (KRW) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 356.65B | 15.65% |
Total assets | 3.04T | 5.31% |
Total liabilities | 824.34B | 6.98% |
Total equity | 2.21T | — |
Shares outstanding | 74.94M | — |
Price to book | 4.21 | — |
Return on assets | 4.13% | — |
Return on capital | 4.94% | — |
Cash Flow
Net change in cash
| (KRW) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | 45.53B | 42.02% |
Cash from operations | 16.76B | 298.76% |
Cash from investing | 3.57B | 193.21% |
Cash from financing | -21.69B | -223.55% |
Net change in cash | -2.96B | -117.12% |
Free cash flow | -33.65B | -3,318.35% |
About
Yuhan Corporation is a South Korean pharmaceutical and chemical company headquartered in Daebang-dong, Dongjak-gu, Seoul. It was established in 1926 by New Il-han and has been listed on the Korea Stock Exchange since 1962. Yuhan is one of the top Korean pharmaceutical companies, along with Celltrion, Samsung Biologics, GC Pharma, and Hanmi Pharmaceutical. Wikipedia
CEO
Founded
1926
Website
Employees
2,066
